US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist
  • 14.160
  • -0.130-0.91%
Close Sep 27 16:00 ET
  • 14.250
  • +0.090+0.64%
Post 20:01 ET
1.41BMarket Cap-7298P/E (TTM)

About Day One Biopharmaceuticals Company

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.

Company Profile

SymbolDAWN
Company NameDay One Biopharmaceuticals
Listing DateMay 27, 2021
Issue Price16.00
Founded2018
CEODr. Jeremy Bender
MarketNASDAQ
Employees155
Fiscal Year Ends12-31
Address2000 Sierra Point Parkway,Suite 501
CityBrisbane
ProvinceCalifornia
CountryUnited States of America
Zip Code94005
Phone1-650-484-0899
Websitehttp://www.dayonebio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jeremy Bender
  • Chief Executive Officer, President and Director
  • 6.91M
  • Adam Dubow
  • General Counsel and Chief Compliance Officer
  • 2.77M
  • Charles N. York, II
  • Principal Accounting Officer, Chief Operating Officer, Chief Financial Officer and Secretary
  • 3.55M
  • Garry A. Nicholson
  • Chairman of the Board
  • 383.38K
  • Habib Joseph Dable
  • Director
  • --
  • Dr. William Grossman
  • Director
  • --
  • Saira Ramasastry, M.Phil,M.S.
  • Independent Director
  • 351.75K
  • Natalie C. Holles
  • Lead Independent Director
  • 352.50K
  • Dr. John A. Josey, PhD
  • Independent Director
  • 350.75K
  • Scott Garland
  • Independent Director
  • 342.88K
  • Michael Gladstone
  • Independent Director
  • 342.88K
  • Dr. Samuel Blackman, M.D.
  • Head of Research and Development
  • 2.49M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data